Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy [Phase 4]
A Phase 4 clinical trial sponsored by Mayo Clinic comparing telehealth and in-person assessments in glioma patients undergoing oral chemothe…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]
A Phase 2 clinical trial evaluating WP1066 with radiation therapy for newly diagnosed glioblastoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations [Phase 2]
Phase 2 trial of pemigatinib in previously treated glioblastoma and other primary CNS tumors with FGFR1-3 alterations was terminated; result…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma [Phase 1]
This update describes a Phase I clinical trial of an mRNA vaccine for recurrent or progressive high-grade glioma that is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma [Phase 1]
A Phase 1 study evaluating tumor treating fields with hypofractionated chemoradiotherapy in newly diagnosed glioblastoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma [Phase 1]
This clinical trial update reports on a novel gamma-delta (γδ) T cell therapy being studied for newly diagnosed glioblastoma in adults; the …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma [Phase 2]
This is a Phase 2 trial evaluating the addition of ruxolitinib to radiation and temozolomide for newly diagnosed glioblastoma. The study is …
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence [NA]
Clinical trial update reports completion of a study evaluating artificial intelligence-guided supramarginal resection for glioblastoma.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment [Phase 2]
A Phase 2 trial comparing ketogenic diet with standard anti-cancer diet guidance in patients with glioblastoma receiving standard-of-care tr…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors was terminated. The sponsor was Novartis Pharmaceuticals, and the t…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer [Phase 1]
A Phase 1 study is evaluating the safety and tolerability of AZD1390 in combination with radiation therapy for brain cancer, including prima…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme [EARLY_Phase 1]
An early-phase trial is evaluating atezolizumab in combination with pre-surgical brain radiation therapy for glioblastoma and is currently r…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients [Phase 2]
This is an update on a Phase 2 clinical trial evaluating valganciclovir in patients with glioblastoma; the study (NCT04116411) is currently …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Clinical Study of Oncolytic Virus in Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating an oncolytic virus for glioblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma [Phase 1]
Phase 1 study of TRIAPINE in combination with temozolomide for recurrent glioblastoma and recurrent gliomas; currently listed as active but …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the combination of atezolizumab and cabozantinib for recurrent glioblastoma and recurrent gliosarco…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging [Phase 2]
Phase 2 pilot study assessing feasibility of combining a ketogenic diet with metformin for glioblastoma, with metabolic imaging endpoints; c…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma [NA]
This clinical trial update reports on a completed study that evaluated whether 18F-fluorodeoxyglucose PET and brain perfusion CT can predict…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
The FET-PET/MRI based treatment planning trial for glioblastoma multiforme in post-surgical patients has completed.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma [Phase 1]
A Phase 1 clinical trial in pediatric patients with recurrent high-grade glioma evaluating hematopoietic stem cell therapy in combination wi…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms [Phase 1]
Phase I trial update indicates ONC206 is being studied for recurrent and rare primary central nervous system neoplasms and the study is curr…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma [Phase 2]
A Phase 2 trial of Paxalisib in glioblastoma, evaluating a high-fat, low-carb diet with metformin, has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial [EARLY_Phase 1]
This document reports the termination of a Phase 0/early Phase 1 trial evaluating repurposed posaconazole for glioblastoma, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma [NA]
This update reports that the clinical trial examining FDG PET/CT for monitoring very early therapy response in glioblastoma has completed.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. [Phase 1]
Phase 1 trial update on an adenovirus-mediated suicide gene therapy combined with radiotherapy for progressive astrocytoma; the study is cur…